BrightInsight Revenue and Competitors

Claim your profile

Location

#388

Growjo Ranking

Estimated Revenue & Valuation

  • BrightInsight's estimated annual revenue is currently $37.5M per year.(i)
  • BrightInsight's estimated revenue per employee is $150,500
  • BrightInsight's total funding is $166M.
  • BrightInsight's current valuation is $750M. (March 2021)

Employee Data

  • BrightInsight has 249 Employees.(i)
  • BrightInsight grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$255.3M127558%$65MN/A
#2
$32.8M2132%N/AN/A
#3
$7.1M5849%$21.3MN/A
#4
$33M21928%$42.9MN/A
#5
$7.7M63-19%$35MN/A
#6
$0.6M9N/AN/AN/A
#7
$37M24024%N/AN/A
#8
$15.1M108-38%$96.4MN/A
#9
$7.9M65-29%$75.6MN/A
#10
$0.4M13-75%$24.9MN/A

BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Our medical-grade Internet of Things (IoT) platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. Our BrightInsight? Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates the time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets. At BrightInsight, our vision is to transform patient outcomes globally by bringing the power of digital technology to healthcare. Our mission is to accelerate regulated digital health innovation for our biopharma and medtech customers through our scalable medical-grade platform. Whether you?re connecting a medical device or combination product, developing a companion app or deploying a smart algorithm, we make digital transformation easy while accelerating your time to market, minimizing your risk and future-proofing your digital health offerings.

keywords:saas

$166M

Total Funding

249

Number of Employees

$37.5M

Revenue (est)

5%

Employee Growth %

$750M

Valuation

N/A

Accelerator

BrightInsight News

2022-03-22 - Four Strategies For Scaling Digital Health Solutions

Kal Patel, MD, is CEO and Co-Founder of BrightInsight. He has over 20 years of experience in pharma, medtech and regulated digital health.

2022-03-22 - BrightInsight and UCB Partner to Build Digital Care Solutions ...

BrightInsight replaces the need for lengthy and complex 'build from scratch' implementations by offering configurable software solutions and a...

2021-03-30 - BrightInsight Announces $101M in Series C Funding led by General Catalyst

SAN JOSE, Calif., March 30, 2021 (GLOBE NEWSWIRE) -- BrightInsight, Inc., provider of the leading global regulated digital health platform for biopharma and medtech, today announced a Series C financing of $101M led by world-renowned venture capital firm General Catalyst. This funding will enabl ...

2020-06-26 - Digital Health Platform BrightInsight Closes $40 Million

BrightInsight, a provider of the leading global regulated digital health platform for biopharma and medtech, announced that it raised $40 million BrightInsight, a provider of the leading global regulated digital health platform for biopharma and medtech, announced that it raised $40 million in ...

2020-06-23 - BrightInsight Raises $40M in Series B Funding

BrightInsight, Inc., a San Jose, Calif.-based provider of a global regulated digital health platform for biopharma and medtech, raised $40M in Series B funding. The round was led by Insight Partners, with participation from Series A investors New Leaf Venture Partners and Eclipse Ventures. Pete ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$57.8M2505%N/A
#2
$74.3M2502%N/A
#3
$54.9M250-33%N/A
#4
$40M25137%N/A
#5
$59.6M2529%$226M